RNA protein kinase SNP at −226 C<T is a biomarker for the clearance of HCV among Egyptian patients

Ahmed WahidDepartment of Pharmacology and Toxicology, Faculty of Pharmacy, Alexandria University, Alexandria, EgyptCorrespondence[email protected]
View further author information

Mustafa A. HamzawyDepartment of Biochemistry, Faculty of Pharmacy, Minia University, Minia, EgyptView further author information

Mohamad M. A. KhalifaDepartment of Pharmacology, Faculty of Pharmacy, Minia University, Minia, EgyptView further author information

Gamal F. M. GadDepartment of Microbiology and Immunology, Faculty of Pharmacy, Minia University, Minia, EgyptView further author information

Amany BekhitDepartment of Biochemistry, Faculty of Pharmacy, Minia University, Minia, EgyptView further author information

Sayed F. AbdelwahabDepartment of Microbiology and Immunology, Faculty of Medicine, Minia University, Minia, Egypt;Department of Microbiology, College of Pharmacy, Taif University, KSA

http://orcid.org/0000-0002-9636-7485 View further author information

RNA protein kinase SNP at −226 C<T is a biomarker for the clearance of HCV among Egyptian patients

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

RNA protein kinase SNP at −226 C<T is a biomarker for the clearance of HCV among Egyptian patients

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date